Essayer OR - Gratuit

Market trends: Cardiovascular devices

Healthcare Radius

|

April 2023

The growing incidence of cardiovascular diseases (CVDs) is providing a strong boost to uptake of cardiovascular devices in India. A report on the latest trends in this category

- NAGESH JOSHI

Market trends: Cardiovascular devices

Cardiovascular diseases (CVDs) have become a significant health concern in India, leading to a high incidence rate of mortality and disability. According to the World Health Organization (WHO), the death rate for CVDs in India is 272 per one lakh population, which is higher than the global average of 235. In recent years, the prevalence of CVDs in India has increased rapidly due to lifestyle changes and risk factors such as hypertension, diabetes mellitus, dyslipidemia, physical inactivity, diet, and addiction.

Cardiovascular diseases (CVDs) are a significant cause of mortality worldwide. In India, CVDs account for 28 percent of all deaths, with ischemic heart disease and stroke being the two most common causes. To combat this rising issue, the medical industry has emphasized the need for technology-driven investigative and therapeutic modalities, including imaging, cath lab, angiographic radiographic tools, contrast agents, and electronically implanted cardiovascular devices. Cardiovascular devices have become instrumental in diagnosing and managing arrhythmia, heart failure, coronary artery disease, valvular heart disease, and other heart conditions. With increasing economic status and a growing focus on healthcare, there has been a significant rise in the adoption levels of advanced cardiovascular devices, promoting medical tourism.

India has a higher mortality rate due to CVDs in the 40-69 year age group, and the incidence of the disease is spreading like a mini-pandemic. Diagnostic tools such as Electrocardiogram machines, Echocardiography (USG), Holter monitoring, X-ray, CT, and MRI are used to diagnose and treat major cardiovascular conditions and improve the quality of life. USG devices, such as 2D echo, are used to analyze cardiac functions and detect structural cardiac abnormalities.

PLUS D'HISTOIRES DE Healthcare Radius

Healthcare Radius

Healthcare Radius

VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM

Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.

time to read

1 mins

December 2025

Healthcare Radius

Healthcare Radius

A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026

The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.

time to read

12 mins

December 2025

Healthcare Radius

Healthcare Radius

FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA

From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.

time to read

6 mins

December 2025

Healthcare Radius

ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US

Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS

Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL

Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH

Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS

By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”

time to read

7 mins

December 2025

Healthcare Radius

Healthcare Radius

MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM

Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.

time to read

1 min

December 2025

Translate

Share

-
+

Change font size